Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Axa S.A.

Axa S.A. cut its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 45.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 23,344 shares of the company’s stock after selling 19,278 shares during the quarter. Axa S.A.’s holdings in Molina Healthcare were worth $6,940,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in MOH. Wellington Management Group LLP raised its position in shares of Molina Healthcare by 12.8% in the 4th quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock valued at $1,384,215,000 after purchasing an additional 436,060 shares during the last quarter. Swedbank AB acquired a new position in Molina Healthcare during the 1st quarter valued at approximately $69,320,000. Jupiter Asset Management Ltd. raised its holdings in shares of Molina Healthcare by 434.6% in the second quarter. Jupiter Asset Management Ltd. now owns 185,606 shares of the company’s stock worth $55,181,000 after buying an additional 150,890 shares during the last quarter. Capital Research Global Investors lifted its stake in shares of Molina Healthcare by 5.4% during the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock worth $878,086,000 after buying an additional 123,894 shares during the period. Finally, Renaissance Technologies LLC grew its holdings in shares of Molina Healthcare by 13.3% during the second quarter. Renaissance Technologies LLC now owns 949,691 shares of the company’s stock valued at $282,343,000 after buying an additional 111,154 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Activity at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, CAO Maurice Hebert sold 393 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the sale, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

MOH has been the subject of a number of research analyst reports. Jefferies Financial Group reduced their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research note on Wednesday, July 24th. Truist Financial reduced their price objective on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a research note on Monday, July 15th. StockNews.com lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, September 18th. Cantor Fitzgerald restated an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a research note on Tuesday, September 10th. Finally, Wells Fargo & Company raised their target price on shares of Molina Healthcare from $315.00 to $360.00 and gave the stock an “equal weight” rating in a report on Monday, August 5th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $378.00.

Molina Healthcare Stock Performance

NYSE MOH opened at $341.86 on Friday. The stock has a market capitalization of $20.03 billion, a price-to-earnings ratio of 18.55, a PEG ratio of 1.21 and a beta of 0.57. The stock has a 50-day moving average of $340.66 and a 200 day moving average of $341.76. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. Molina Healthcare, Inc. has a twelve month low of $282.96 and a twelve month high of $423.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, topping the consensus estimate of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The company had revenue of $9.88 billion during the quarter, compared to analyst estimates of $9.75 billion. During the same quarter in the previous year, the firm earned $5.65 EPS. The firm’s revenue was up 18.7% compared to the same quarter last year. Sell-side analysts anticipate that Molina Healthcare, Inc. will post 23.5 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.